Superworth

AbbVie EPS ABBV

Diluted earnings per share by quarter and over the last twelve months, from 2012.

Last 12 months, to Jun 30, 2026
$3.54
Latest quarter, Q2 FY26
$2.03
+290% on a year earlier
Fiscal year 2025
$2.36
−2% on the year before

AbbVie's earnings per share was $3.54 over the twelve months to Jun 30, 2026, up 69% on a year earlier.

In its latest quarter, Q2 FY26, it was $2.03, up 290% on the same quarter a year before.

Over the five fiscal years to FY2025 it shrank 4% a year on average.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$2.36−2%
FY2024$2.40−12%
FY2023$2.73−59%
FY2022$6.61+2%
FY2021$6.45+126%
FY2020$2.86−46%
FY2019$5.28+47%
FY2018$3.58+9%
FY2017$3.29−9%
FY2016$3.63+16%
FY2015$3.12+186%
FY2014$1.09−57%
FY2013$2.56−24%
FY2012$3.35n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$2.03+290%$3.54
Q1 FY26$0.39−46%$2.03
Q4 FY25$1.02n/a$2.36
Q3 FY25$0.10−89%$1.32
Q2 FY25$0.52−32%$2.10
Q1 FY25$0.72−6%$2.35
Q4 FY24−$0.02−104%$2.40
Q3 FY24$0.88−12%$2.88
Q2 FY24$0.77−32%$3.00
Q1 FY24$0.77+492%$3.37
Q4 FY23$0.46−67%$2.73
Q3 FY23$1.00−55%$3.65

Against its peers

Companies in Drug Manufacturers - General nearest AbbVie's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ABBVAbbVie$3.54+69% a year
JNJJohnson & Johnson$6.60−36% a year
MRKMerck$1.25−81% a year
AMGNAmgen$16.09+32% a year
LLYEli Lilly and$29.80+95% a year
GILDGilead Sciences−$2.67−153% a year
PFEPfizer$0.76−60% a year
BMYBristol-Myers Squibb$4.54+83% a year
Peer median$4.54

Where AbbVie ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on AbbVie

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.